H&T Presspart, the global leader in the manufacture of metered-dose inhaler components, are pleased to announce they will be sponsoring this year’s virtual Drug Delivery to the Lungs conference which is being held from 8-11th December.

As well as sponsoring the event, H&T Presspart will also be taking in part in the DDL virtual exhibition, showcasing the full range of respiratory drug delivery components and devices including our plasma treatment process – available only from H&T Presspart – which improves the surface energy performance of an MDI canister, whilst enhancing drug stability in formulations where interactions with the aluminium substrate can lead to product degradation and reduced shelf life.

Although the conference is being held virtually for a second year running amid the ongoing difficulties being faced internationally due to the COVID19 pandemic, the conference and virtual exhibition is still an event not to be missed as DDL attracts a wide variety of attendees, including scientists, academics, clinicians, regulators and industry experts.

We wish the organisers and all virtual attendees a great show and if you would like to get in touch with any questions about the event or to organise a meeting during DDL2021, please visit get in touch.

We look forward to seeing everyone face to face in 2022.